India  

BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccines

DNA Sunday, 3 January 2021 ()
The approval comes after the clearances from the Subject Expert Committee (SEC).
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech

DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech 02:10

Drugs Controller General of India VG Somani on January 03 informed that COVID-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in emergency situation.

You Might Like


💡 newsR Knowledge: Other News Mentions

Drugs Controller General of India

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval [Video]

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India. ‘Government should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said. The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved. The first phase of coronavirus vaccination is all set to begin on 16th January, 2021. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 01:40Published
Explained: India announces Covid vaccination launch date; who's first in line? [Video]

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government. Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII). Around 30 crore people are being targeted for vaccination in phase 1. These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities. Watch the full video for more.

Credit: HT Digital Content    Duration: 01:34Published

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said..
IndiaTimes

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Republic Day: Security measures tightened in anticipation of terror threat

Due to the COVID pandemic, no foreign guest will be present at India's Republic Day parade,
DNA
UP records 404 new COVID cases, 666 recoveries in last 24 hours [Video]

UP records 404 new COVID cases, 666 recoveries in last 24 hours

Uttar Pradesh Additional Chief Secretary, Health, Amit Mohan Prasad on January 17 informed about the current situation of the state. He said that as many as 404 new COVID-19 cases have been recorded in the state in past 24 hours. Whereas, 666 people have been discharged in the same duration. Active cases in the state are 8881 in which 3210 people are in home isolation.

Credit: ANI    Duration: 01:17Published

More than half of over-80s have received COVID vaccine as 140 jabs given a minute

More than half of over-80s have received at least one dose of a coronavirus vaccine, as the government has revealed that 140 jabs are being given out a minute. 
Sky News

Related videos from verified sources

India launches world's largest vaccination drive [Video]

India launches world's largest vaccination drive

India on Saturday (January 16) launched the world's largest vaccination drive after receiving millions of doses of two approved vaccines - Covishield and Covaxin.

Credit: Newsflare STUDIO     Duration: 02:05Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive [Video]

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive

Union health minister Dr Harsh Vardhan said that the vaccination drive is 'beginning of the end of covid-19'. He reviewed the preparedness ahead of the Covid-19 vaccination drive in India. "World's..

Credit: HT Digital Content     Duration: 03:02Published
Covid-19: First vaccine shots likely on January 13th, countdown begins|Oneindia News [Video]

Covid-19: First vaccine shots likely on January 13th, countdown begins|Oneindia News

Indians can expect to get their first COVID-19 vaccine shot on January 13. Union Health Ministry announced on Tuesday that the Centre is all set to roll out coronavirus vaccines within 10 days of..

Credit: Oneindia     Duration: 01:00Published